Author

Trilochan Mukkur

Unknown affiliation - Cited by 2,984

Biography

Trilochan Mukkur, is worked for School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University [Bentley Campus], Perth 6102, Western Australia and he worked on Development of Affordable Effective Vaccines against Whooping Cough for the Developing World. His research interest include Vaccines, Immunization, Cough vaccines, Virology, Immunology, Clinical trials, Vaccination, Vaccinology
Title
Cited by
Year
Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems
S Sharma, TKS Mukkur, HAE Benson, Y ChenJournal of pharmaceutical sciences 98 (3), 812-843, 2009200
198
2009
RNA interference therapeutics for cancer: challenges and opportunities
RS Bora, D Gupta, TKS Mukkur, KS SainiMolecular medicine reports 6 (1), 9-15, 2012201
148
2012
Trends in therapeutic and prevention strategies for management of bovine mastitis: an overview
JG Tiwari, C Babra, H Tiwari, V Williams, S De Wet, J Gibson, A Paxman, ...Journal of Vaccines & Vaccination 4 (1), 1-11, 2013201
112
2013
Isolation, Biochemical and Molecular Identification, and In-Vitro Antimicrobial Resistance Patterns of Bacteria Isolated from Bubaline Subclinical Mastitis in South …
PL Preethirani, S Isloor, S Sundareshan, V Nuthanalakshmi, ...PLoS One 10 (11), e0142717, 2015201
76
2015
Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol
A Mooranian, R Negrulj, N Chen-Tan, HS Al-Sallami, Z Fang, TK Mukkur, ...Drug design, development and therapy, 1221-1230, 2014201
74
2014
Rapid-Cycle PCR Method To Detect Bordetella pertussis That Fulfills All Consensus Recommendations for Use of PCR in Diagnosis of Pertussis
DJ Farrell, M McKeon, G Daggard, MJ Loeffelholz, CJ Thompson, ...Journal of clinical microbiology 38 (12), 4499-4502, 2000200
73
2000
Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance
D Dorji, F Mooi, O Yantorno, R Deora, RM Graham, TK MukkurMedical microbiology and immunology 207, 3-26, 2018201
67
2018
Stability and release kinetics of an advanced gliclazide-cholic acid formulation: the use of artificial-cell microencapsulation in slow release targeted oral delivery of …
A Mooranian, R Negrulj, S Mathavan, J Martinez, J Sciarretta, ...Journal of Pharmaceutical Innovation 9, 150-157, 2014201
67
2014
Evaluation of the immunogenicity of the P97R1 adhesin of Mycoplasma hyopneumoniae as a mucosal vaccine in mice
AY Chen, SR Fry, J Forbes-Faulkner, G Daggard, TKS MukkurJournal of medical microbiology 55 (7), 923-929, 2006200
65
2006
An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations
A Mooranian, R Negrulj, S Mathavan, J Martinez, J Sciarretta, ...Pharmaceutical development and technology 20 (6), 702-709, 2015201
63
2015
An investigation on the antimicrobial activity of Andrographis paniculata extracts and andrographolide in vitro
Y Xu, RL Marshall, TKS MukkurAsian journal of plant sciences 5 (3), 527-530, 2006200
62
2006
Nested Duplex PCR To Detect Bordetella pertussis and Bordetella parapertussis and Its Application in Diagnosis of Pertussis in Nonmetropolitan Southeast …
DJ Farrell, G Daggard, TKS MukkurJournal of clinical microbiology 37 (3), 6-610, 1999199
60
1999
Evaluation of immune response to recombinant potential protective antigens of Mycoplasma hyopneumoniae delivered as cocktail DNA and/or recombinant protein …
AY Chen, SR Fry, GE Daggard, TKS MukkurVaccine 26 (34), 4372-4378, 2008200
58
2008
Modulation of immune response in mice immunised with an inactivated Salmonella vaccine and gavaged with Andrographis paniculata extract or andrographolide
Y Xu, A Chen, S Fry, RA Barrow, RL Marshall, TKS MukkurInternational immunopharmacology 7 (4), 515-523, 2007200
55
2007
Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study
A Mooranian, R Negrulj, N Chen-Tan, HS Al-Sallami, Z Fang, T Mukkur, ...Drug design, development and therapy, 1003-1012, 2014201
55
2014
Enhanced immune response against pertussis toxoid by IgA-loaded chitosan–dextran sulfate nanoparticles
S Sharma, TKS Mukkur, HAE Benson, Y ChenJournal of pharmaceutical sciences 101 (1), 233-244, 2012201
54
2012
Development of improved vaccines against whooping cough: current status
I Marzouqi, P Richmond, S Fry, J Wetherall, T MukkurHuman vaccines 6 (7), 543-553, 2010201
50
2010
The persistence of biofilm-associated antibiotic resistance of Staphylococcus aureus isolated from clinical bovine mastitis cases in Australia
C Babra, JG Tiwari, G Pier, TH Thein, R Sunagar, S Sundareshan, ...Folia microbiologica 58, 469-474, 2013201
50
2013
In Vitro Antimicrobial Efficacy of Tobramycin Against Staphylococcus aureus Biofilms in Combination With or Without DNase I and/or Dispersin B: A Preliminary …
CB Waryah, K Wells, D Ulluwishewa, N Chen-Tan, J Gogoi-Tiwari, ...Microbial Drug Resistance 23 (3), 384-390, 2017201
47
2017
Comparative immunogenicity of M. hyopneumoniae NrdF encoded in different expression systems delivered orally via attenuated S. typhimurium aroA in mice
AY Chen, SR Fry, J Forbes-Faulkner, GE Daggard, TKS MukkurVeterinary microbiology 114 (3-4), 252-259, 2006200
44
2006

Referred From: https://scholar.google.com/citations?hl=en&user=nErQEpEAAAAJ

Cited by
Citations 2984
h-index 30
i10-index 73
Recommended Journals
Open Access Journals